Journals Papers details


Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022


Author Name : Isra' Mahmoud Khalaf Dmour
Title : Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022
Journal : Journal of Pharmaceutical Innovation
Volum Number : --
Year : 2022
Pages : 1-15
Research Area : Compounding Pharmacy, Regulatory Affairs
URL : Visit Url
Link to Paper : View Paper



Back